40 results on '"Macek Jilkova, Zuzana"'
Search Results
2. Glycolysis Changes in Alloreactive Memory B Cells in Highly Sensitized Kidney Transplant Recipients Undergonig Desensitization Therapy.
3. Harnessing Immune Cell Metabolism to Modulate Alloresponse in Transplantation
4. PD1 and TIM3 Expression is Associated with Very Early Hepatocellular Carcinoma Recurrence After Percutaneous Thermal Ablation
5. Enjeux actuels autour des thérapies combinées de carcinome hépatocellulaire : immunomodulations et vaccins.
6. Immunomodulation for hepatocellular carcinoma therapy: current challenges
7. Data from Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma
8. Supplementary Material and Method, Supplementary Tables 1-2, and Figure Legends from Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma
9. Figure S4 from Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma
10. Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation
11. Rat Model of Hepatocellular Carcinoma for Better Understanding Immune Effects of Transarterial Chemoembolization
12. Immunologic Features of Patients With Advanced Hepatocellular Carcinoma Before and During Sorafenib or Anti-programmed Death-1/Programmed Death-L1 Treatment
13. Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model
14. Enantioselective Approach for Expanding the Three‐Dimensional Space of Tetrahydroquinoline to Develop BET Bromodomain Inhibitors**
15. Chronic Intermittent Hypoxia Increases Cell Proliferation in Hepatocellular Carcinoma
16. Hepatocellular carcinoma hosts immature neurons and cholinergic tumors that correlate with adverse molecular features and outcomes
17. Gamma delta T cells in hepatocellular carcinoma: Sunrise of new therapy based on Vδ2 T cells?
18. Immunomodulation for hepatocellular carcinoma therapy: current challenges
19. Predictive Factors for Hepatocellular Carcinoma Development after Direct-Acting Antiviral Treatment of HCV
20. The Chicken Embryo Model: A Novel and Relevant Model for Immune-Based Studies
21. Increased Intrahepatic Expression of Immune Checkpoint Molecules in Autoimmune Liver Disease
22. DEN-Induced Rat Model Reproduces Key Features of Human Hepatocellular Carcinoma
23. GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal Cancer
24. FRI-289 - Sex disparities in presentation and outcome of hepatocellular carcinoma: results of a nationwide study in France
25. Meeting Abstract: 2143
26. GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal Cancer
27. Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554
28. Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma
29. Percutaneous Ablation-Induced Immunomodulation in Hepatocellular Carcinoma
30. A study of serum miRNA-122 in hepatitis C and associated hepatocellular carcinoma
31. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges
32. Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment
33. Sex Differences in Spontaneous Degranulation Activity of Intrahepatic Natural Killer Cells during Chronic Hepatitis B: Association with Estradiol Levels
34. Immunologie dans le carcinome hépatocellulaire : bases physiopathologiques et cibles thérapeutiques.
35. Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma
36. Progression of fibrosis in patients with chronic viral hepatitis is associated with IL‐17+ neutrophils
37. CCM proteins control endothelial β1 integrin dependent response to shear stress
38. Progression of fibrosis in patients with chronic viral hepatitis is associated with IL-17+ neutrophils.
39. Metabolic Effects of n-3 PUFA as Phospholipids Are Superior to Triglycerides in Mice Fed a High-Fat Diet: Possible Role of Endocannabinoids
40. Enantioselective Approach for Expanding the Three-Dimensional Space of Tetrahydroquinoline to Develop BET Bromodomain Inhibitors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.